Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
NCT02228889 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of the study is to compare the clinical outcomes of two commonly used, FDA-approved biologic meshes in hernia repair and abdominal wall reconstruction (Strattice and XenMatrix). The two meshes are derived from pig skin from which cells have been removed and which have been sterilized. The two meshes are made by two different companies using different processes.
Conditions Studied
Interventions
- PROCEDURE Abdominal wall reconstruction with Strattice
- OTHER Assess pain intensity at last office visit preoperatively
- OTHER Assess pain interference at last office visit preoperatively
- OTHER Assess physical functioning at last office visit preoperatively
- OTHER Assess patient quality of life at last office visit preoperatively
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center — Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-01 |
| Est. Completion | 2025-03-27 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02228889
The ClinicalTrials.gov registry entry for NCT02228889 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jeffrey Janis, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Hernia, Ventral appearing as the primary indexed condition, and to 5 interventions — of which Abdominal wall reconstruction with Strattice is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02228889 reports 1 study location spanning 1 distinct geographic area — top geographies include Ohio. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02228889 about?
NCT02228889 is a clinical study titled "RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction". The purpose of the study is to compare the clinical outcomes of two commonly used, FDA-approved biologic meshes in hernia repair and abdominal wall reconstruction (Strattice and XenMatrix). The two meshes are derived from pig skin from which cells have been removed and which have been sterilized. Th...
What is the current status of trial NCT02228889?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2015-01. Estimated completion is 2025-03-27.
What conditions does trial NCT02228889 study?
This clinical trial studies the following conditions: Hernia, Ventral, Intestinal Fistula, Fibromatosis, Abdominal. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02228889?
The interventions under investigation include: Abdominal wall reconstruction with Strattice (PROCEDURE), Assess pain intensity at last office visit preoperatively (OTHER), Assess pain interference at last office visit preoperatively (OTHER), Assess physical functioning at last office visit preoperatively (OTHER), Assess patient quality of life at last office visit preoperatively (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02228889?
This trial is sponsored by Jeffrey Janis, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02228889 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.